Erin Fran Brooks

Erin Fran Brooks

Auto-generated profile, based on publicly available information

Erin Fran Brooks

Department of Medicine, Division of Hematology, Stanford University, Stanford, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2022 in Med
Verified
Journal Article
Closed access
ANAravind Natarajan
Aravind Natarajan
SZSoumaya Zlitni
Soumaya Zlitni
EBErin F. Brooks
Erin F. Brooks
SVSummer E. Vance
Summer E. Vance
ADAlex Dahlen
Alex Dahlen
ABAmi S. Bhatt
Ami S. Bhatt

22 December 2021 in Nature
Verified
Journal Article
Closed access
PDF file
RBRaymond E. Blackwell
Raymond E. Blackwell
FZFangzhou Zhao
Fangzhou Zhao
EBErin Brooks
Erin Brooks
JZJunmian Zhu
Junmian Zhu
IPIlya Piskun
Ilya Piskun
FFFelix R. Fischer
Felix R. Fischer

31 January 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
BSBenjamin A. Siranosian
Benjamin A. Siranosian
EBErin F. Brooks
Erin F. Brooks
TATessa Andermann
Tessa Andermann
ARAndrew R. Rezvani
Andrew R. Rezvani
NBNiaz Banaei
Niaz Banaei
ABAmi S. Bhatt
Ami S. Bhatt
Bacterial bloodstream infections are a major cause of morbidity and mortality among patients undergoing hematopoietic cell transplantation (HCT). Although previous research has demonstrated that pathogens may translocate from the gut microbiome into the bloodstream to cause infections, the mechanisms by which HCT patients acquire pathogens in their microbiome have not yet been described. Here, we use linked-read and short-read metagenomic sequencing to analyze 401 stool samples collected from 149 adults undergoing HCT and hospitalized in the same unit over three years, many of whom were roommates. We use metagenomic assembly and strain-specific comparison methods to search for high-identity bacterial strains, which may indicate transmission between the gut microbiomes of patients. Overall, the microbiomes of patients who share time and space in the hospital do not converge in taxonomic composition. However, we do observe six pairs of patients who harbor identical or nearly identical strains of the pathogen Enterococcus faecium, or the gut commensals Akkermansia muciniphila and Hungatella hathewayi. These shared strains may result from direct transmission between patients who shared a room and bathroom, acquisition from a common hospital source, or transmission from an unsampled intermediate. We also identify multiple patients with identical strains of species commonly found in commercial probiotics, including Lactobacillus rhamnosus and Streptococcus thermophilus. In summary, our findings indicate that sharing of identical pathogens between the gut microbiomes of multiple patients is a rare phenomenon. Furthermore, the observed potential transmission of commensal, immunomodulatory microbes suggests that exposure to other humans may contribute to microbiome reassembly post-HCT.

1 October 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ANAravind Natarajan
Aravind Natarajan
AHAlvin Han
Alvin Han
SZSoumaya Zlitni
Soumaya Zlitni
EBErin F. Brooks
Erin F. Brooks
SVSummer E. Vance
Summer E. Vance
ABAmi S. Bhatt
Ami S. Bhatt
Patients with COVID-19 shed SARS-CoV-2 RNA in stool, sometimes well after their respiratory infection has cleared. This may be significant for patient health, epidemiology, and diagnosis. However, methods to preserve stool, and to extract and quantify viral RNA are not standardized. We test the performance of three preservative approaches at yielding detectable SARS-CoV-2 RNA: the OMNIgene-GUT kit, Zymo DNA/RNA shield kit, and the most commonly applied, storage without preservative. We test these in combination with three extraction kits: QIAamp Viral RNA Mini Kit, Zymo Quick-RNA Viral Kit, and MagMAX Viral/Pathogen Kit. We also test the utility of ddPCR and RT-qPCR for the reliable quantification of SARS-CoV-2 RNA from stool. We identify that the Zymo DNA/RNA preservative and the QiaAMP extraction kit yield more detectable RNA than the others, using both ddPCR and RT-qPCR. Taken together, we recommend a comprehensive methodology for preservation, extraction and detection of RNA from SARS-CoV-2 and other coronaviruses in stool.

25 September 2024 in Nature
Verified
Journal Article
Closed access
PDF file
RCRachael B. Chanin
Rachael B. Chanin
PWPatrick T. West
Patrick T. West
JWJakob Wirbel
Jakob Wirbel
MGMatthew O. Gill
Matthew O. Gill
GGGabriella Z. M. Green
Gabriella Z. M. Green
ABAmi S. Bhatt
Ami S. Bhatt

16 April 2020 in PLOS Biology
Verified
Journal Article
Open access
PDF file
MMMarni B. McClure
Marni B. McClure
KHKacey C. Hall
Kacey C. Hall
EBErin F. Brooks
Erin F. Brooks
CACatherine T. Allen
Catherine T. Allen
KLKenneth S. Lyle
Kenneth S. Lyle
Encouragement of students across all communities through scientific outreach programs is critical to engaging the next generation, exciting young minds to pursue careers in science and medicine. Herein, we present a uniquely structured and widely influential science outreach program. Founded in 2005, the Duke Chemistry Outreach (DCO) employs a pedagogical approach to outreach that aims to teach its audience a new scientific concept, while instilling a pure enjoyment of science. DCO has performed 583 events reaching over 70,000 participants throughout 2,270 hours, with the majority of events in Durham, the surrounding North Carolinian communities, and across 8 other states. The flexibility and diversity of this outreach program creates a framework amendable for others to adopt in both secondary and higher education settings.